Crohn's disease may develop from warped immune cell signaling during bile acid exposure Study reveals how T cells in the small intestine respond to bile acids, offering localized treatment direction for a cause of chronic illness.
April 07, 2021
JUPITER, FL People with Crohn's disease are typically treated with powerful anti-inflammatory medications that act throughout their body, not just in their digestive tract, creating the potential for unintended, and often serious, side effects. New research from the lab of Mark Sundrud, PhD, at Scripps Research, Florida suggests a more targeted treatment approach is possible.
Crohn's disease develops from chronic inflammation in the digestive tract, often the small intestine. More than half a million people in the United States live with the disease, which can be debilitating and require repetitive surgeries to remove irreversibly damaged intestinal tissue.
Writing in the journal Nature, Sundrud's team finds that certain immune cells in the small intestine have evolved a molecular sensing mechanism to protect themselves from the toxic effects of high bile acid concentrations in the small intestine. This sensory mechanism can be manipulated with small drug-like molecules, they find, and the treatment reduced small bowel inflammation in mice.
It seems that these immune cells, called T effector cells, have learned how to protect themselves from bile acids, Sundrud says. These T cells utilize an entire network of genes to interact safely with bile acids in the small intestine. This pathway may malfunction in at least some individuals with Crohn's disease.
Bile acids are made in the liver and released during a meal to help with digestion and absorption of fats and fat-soluble vitamins. They are actively recaptured at the end of the small intestine, in an area called the ileum, where they pass through layers of tissue that contain the body's dense network of intestinal immune cells, and ultimately re-enter the blood stream for return to the liver.
Because they are detergents, bile acids can cause toxicity and inflammation if the system becomes unbalanced. The whole process is kept humming along thanks to an intricate signaling system. Receptors in the nucleus of both liver cells and intestinal barrier cells sense the presence of bile acid and tell the liver to back off on bile acid production if there's too much, or to produce more if there aren't enough to digest a big steak dinner, for example.
Given how damaging bile acids can potentially be to cells, scientists have wondered how immune cells that live in or visit the small intestine tolerate their presence at all. Sundrud's team previously reported that a gene called MDR1, also known as ABCB1, becomes activated when an important subset of immune cells that circulate in blood, called CD4+ T cells, make their way into the small intestine. There, MDR1 acts in transitory T cells to suppress bile acid toxicity and small bowel inflammation.
In the new study, Sundrud's team uses an advanced genetic screening approach to uncover how T cells sense and respond to bile acids in the small intestine to increase MDR1 activity.
The basic discovery that T cells dedicate so much of their time and energy to preventing bile acid-driven stress and inflammation highlights completely new concepts in how we think about and treat Crohn's disease, Sundrud says. It's like we've been digging in the wrong spot for treasure, and this work gives us a new map showing where X marks the spot.
The T cells contain a receptor molecule in their nucleus known as CAR, short for constitutive androstane receptor. Acting in the small intestine, CAR promotes expression of MDR1, and also plays a role in activating an essential anti-inflammatory gene, IL-10, the team found.
When we treated mice with drug-like small molecules that activate CAR, the result was localized detoxification of bile acids and reduction of inflammation, Sundrud says.
Sundrud says exploring the therapeutic potential of CAR activation will require caution and creativity, because CAR is also critical for breaking down and eliminating other substances in the liver, including many medicines.
Ultimately, the Crohn's disease therapy that emerges from this work could be something that activates CAR locally in small intestinal T cells, or something that targets another gene that is similarly responsible for promoting the safe communication between small intestinal T cells and bile acids, Sundrud says.
Also interesting, the team found that the bile acid-inflammation feedback system worked somewhat differently in the colon in concert with gut microbiome factors. While gut flora had more influence on T cell development and function in the colon, it was the nuclear receptor CAR that had more influence on inflammation in the small intestine.
Inflammation plays both positive and negative roles in the body. It can damage tissue, but it also suppresses cancer growth and fights infections. The current anti-inflammatory treatments shut it down systemically, throughout the entire body. That can have potentially serious consequences, such as lowering resistance to infections or easing off the brake on cancer. Directing treatment for inflammatory diseases only to the affected tissue would be preferable whenever feasible, he says.
The roughly 50 million people living in the US with some sort of autoimmune or chronic inflammatory disease are all treated the same, medically, Sundrud says. The holy grail would be to come up with druggable approaches to treat inflammation in only specific tissues and leave the rest of the immune cells in your body untouched, and able to fend of cancer and microbial infections.
In addition to lead author Mark Sundrud, the authors of the study, CAR directs T cell adaptation
Europe Stories
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
01/06/2026
January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026
Throughout the week, Dolby brings to life the latest innovatio...
07/05/2026
Journalists reporting on Sudan are working in one of the most complex and fast-m...
07/05/2026
Seit dem Start im Jahr 2023 hat DJ (Beta) das personalisierte H rerlebnis von 94...
07/05/2026
Da quando stata presentata nel 2023, DJ (beta) ha aiutato a definire un'esperienza d'ascolto pi personalizzata per 94 milioni di utenti Spotify Premi...
07/05/2026
Since launching in 2023, DJ (beta) has helped shape a more personalized listenin...
07/05/2026
Desde o lan amento em 2023, o DJ (beta) j ajudou a deixar a experi ncia de ouvi...
07/05/2026
From our earliest days, Spotify has been built on a simple principle: Great audio should be easy to reach. It's what's driven us to expand from music to...
07/05/2026
Asian and Pacific Islander artists continue to shape the global soundscape, pushing creative boundaries and connecting with fans worldwide. This Asian & Pacific...
07/05/2026
Company announce long-requested choir instrument
In the latest expansion of their Symphonic Elements series, UJAM have introduced an all-new vocal instrumen...
07/05/2026
Modular-inspired sound generation with digital control
Buchla have introduced Ziggy, a new compact synthesizer built around the company's complex oscill...
07/05/2026
Combines analogue voices with digital synthesis and sequencing
Polyend have announced Drums, a new hybrid analogue and digital drum machine that combines sy...
07/05/2026
Control surface now officially supports four DAWs
When Nektar launched the Panorama CS12 control surface, it worked exclusively with Apple's Logic Pro, ...
07/05/2026
In the first quarter 2026, SGL Carbon generated consolidated sales of 184.5 million, which was 49.8 million, or 21.3%, lower than in the prior year (Q1 2025: ...
07/05/2026
Rohde & Schwarz and Greenerwave achieve precise and fast ESA antenna characteriz...
07/05/2026
January 8, 2024
Colorfront (colorfront.com), a leader in high-performance, on-s...
07/05/2026
February 9, 2024
Colorfront (colorfront.com), the multi-award-winning pioneer i...
07/05/2026
March 20, 2024
NAB 2024, Las Vegas - Colorfront (colorfront.com), the multi-awa...
07/05/2026
April 1, 2025
CINEMACON, APRIL 1, 2025 - Colorfront (colorfront.com), the multi-award-winning developer of high-performance dailies/transcoding/streaming syste...
07/05/2026
June 15, 2025
Colorfront (colorfront.com), an Academy and Emmy Award-winning de...
07/05/2026
June 15, 2025
Colorfront participated in the ICTA Barcelona Cinema Technology Summit on Sunday, June 15, 2025. Held at The Phenomena Experience, the event feat...
07/05/2026
July 1, 2025
Colorfront (colorfront.com), the multi-award-winning developer of high-performance dailies/transcoding/streaming systems for motion pictures, OTT,...
07/05/2026
July 1, 2025
Passion and dedication will take you places. Come with us on a short trip to the heart of India, where Annapurna Studios is living-up to the inspi...
07/05/2026
July 3, 2025
Colorfront (colorfront.com), the multi-award-winning developer of high-performance dailies/transcoding/streaming systems for motion pictures, OTT,...
07/05/2026
September 1, 2025
IBC 2025, Amsterdam - Colorfront (colorfront.com) - the Acade...
07/05/2026
April 17, 2026
LOS ANGELES - April 17, 2026 - Colorfront today announced Colorf...
07/05/2026
April 23, 2026
NAB 2026, Las Vegas - the Academy and Emmy Award-winning develop...
07/05/2026
Thursday 7 May 2026
Sky continues Sphere Abacus partnership with The Death of S...
07/05/2026
Thursday 7 May 2026
Sky Confirms Saturday Night Live UK will return this September for Series Two
Saturday Night Live UK will return for a second series, as S...
07/05/2026
Save 20% on the Sky Glass Gen 2 and Sky Glass Air TVsThursday 7 May 2026
How to watch the World Cup on Sky Glass
Tune into the World Cup on the BBC and ITV vi...
07/05/2026
Production sound mixer Dirk Sciarrotta has mixed Family Feud for 28 seasons. Thats up to 200 syndicated episodes per year, plus primetime celebrity specials - a...
07/05/2026
As audience expectations have evolved, Owen has stopped trying to hide microphones or excuse amplification. Instead, he treats sound as a fully immersive part o...
07/05/2026
Well known Irish faces pushed to the edge in new series of
Uncharted with Ray G...
07/05/2026
RT will premiere A Traveller Family, a compelling new documentary exploring the...
06/05/2026
New pricing tiers for vocal/dialogue restoration tool
NoiseWorks Audio's AI-powered vocal and dialogue processing plug-in is now available in three diff...
06/05/2026
Popular mixing & routing software overhauled
Following a recent public beta test, RME have launched the final release version of the powerful mixing and rou...
06/05/2026
New SOS Video Feature
Focusrites ISA C8X is a milestone product that brings together the companys analogue heritage and their expertise in digital audio. Yo...
06/05/2026
06 May 2026
VEON's Kyivstar Authorized to Resell Starlink for Businesses & ...
06/05/2026
UKTV has secured the exclusive rights to the early back catalogue of iconic Australian drama series Neighbours, following a landmark content deal with Fremantle...
06/05/2026
Wednesday 6 May 2026
Sky commissions feature documentary to mark 10th anniversa...
06/05/2026
Wednesday 6 May 2026
Sky and Formula 1 agree long-term partnership across UK, Ireland and Italy
Sky in the UK & Ireland to remain the home of Formula 1 until ...
06/05/2026
Sky Zero Footprint Fund-backed TV campaign launches nationwide, supported by new...
06/05/2026
Wuppertal May 6, 2026
Riedel Expands Leadership Structure, Appoints Marc Engro...
06/05/2026
SAN JOSE, Calif. - May 6, 2026 - Harmonic (NASDAQ: HLIT) today announced its latest broadband innovations for ANGA COM 2026, highlighting its vision for a new e...
06/05/2026
Statement from Rupert Murdoch, Chairman Emeritus, Fox Corporation on Ted Turner&...
06/05/2026
Friday 8 May on RT One and RT Player
Meet the NSPCA team caring for and protecting animals in need in this six-part series
Fly on the wall, six-part series...
Crohn's disease may develop from warped immune cell signaling during bile acid exposure Study reveals how T cells in the small intestine respond to bile acids, offering localized treatment direction for a cause of chronic illness.
